Chagas Disease in the United States: a Public Health Approach
- PMID: 31776135
- PMCID: PMC6927308
- DOI: 10.1128/CMR.00023-19
Chagas Disease in the United States: a Public Health Approach
Abstract
Trypanosoma cruzi is the etiological agent of Chagas disease, usually transmitted by triatomine vectors. An estimated 20 to 30% of infected individuals develop potentially lethal cardiac or gastrointestinal disease. Sylvatic transmission cycles exist in the southern United States, involving 11 triatomine vector species and infected mammals such as rodents, opossums, and dogs. Nevertheless, imported chronic T. cruzi infections in migrants from Latin America vastly outnumber locally acquired human cases. Benznidazole is now FDA approved, and clinical and public health efforts are under way by researchers and health departments in a number of states. Making progress will require efforts to improve awareness among providers and patients, data on diagnostic test performance and expanded availability of confirmatory testing, and evidence-based strategies to improve access to appropriate management of Chagas disease in the United States.
Keywords: Chagas disease; Trypanosoma cruzi; United States; triatomine.
Copyright © 2019 American Society for Microbiology.
Figures



References
-
- World Health Organization. 2015. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 90:33–44. - PubMed
-
- World Health Organization. 2018. Global health estimates 2016 summary tables: DALYs by cause, age and sex, by WHO region, 2000–2016. World Health Organization, Geneva, Switzerland: https://www.who.int/healthinfo/global_burden_disease/GHE2016_DALY_WHOReg....
-
- López-Vélez R, Norman FF, Bern C. 2019. American trypanosomiasis (Chagas disease), p 762–765. In Ryan ET, Hill DR, Solomon T, Endy TP, Aronson N (ed), Hunter’s tropical medicine and emerging infectious disease, 10th ed Elsevier, London, United Kingdom.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical